New feature: Customize your PLUS research experience with
My Preferences
.
Learn more
.
Skip to main content
Create Account
Training Center
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Insights
- Treatises
Forms & Checklists
Transcripts
My Bookshelf
My History
< Back To Results
1 in 1 results
Previous Result
Next Result
Developments in Pharmaceutical and Biotech Patent Law 2018
Chair(s):
Daniel L. Reisner
Practice Area:
Biotechnology,
Intellectual property,
Life sciences,
Patents,
Pharmaceuticals
Published:
Oct 2018
i
Other versions can be found in the
Related Items
tab.
ISBN:
9781402432545
PLI Item #:
219403
CHB Spine #:
G1389
This version is not current.
Click here for the most recent version.
Search
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. IPRs: Oil States, SAS, and Other Developments
Chapter 2. Preliminary and Permanent Injunctions in Life Sciences Patent Litigation
Chapter 3. Patenting Biologics—Antibodies, Proteins and Cell-Based Therapies
Chapter 4. United States Patent and Trademark Office, Memorandum, Clarification of Written Description Guidance for Claims Drawn to Antibodies and Status of 2008 Training Materials (February 22, 2018); Subject Matter Eligibility Examples: Life Sciences; United States Patent and Trademark Office, Memorandum, Recent Subject Matter Eligibility Decision: Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals (June 7, 2018)
Chapter 5. Complaint for Patent Infringement, Amgen Inc. v. Apotex Inc. (S.D. Fla. Aug. 7, 2018)
Chapter 6. Actavis and “Reverse-Payment” Settlements of Hatch-Waxman Patent Litigation
Chapter 7. Sanjay K. Murthy and Maria E. Doukas, Ethical Issues Confronting Life Sciences Patent Lawyers
Index
About Us